Innospec Stock (NASDAQ:IOSP), Trade Ideas

Innospec

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

News

Markets

Trading Ideas

IOSP

United States Steel Corporation (NYSE: X) said that its shareholders have approved its proposed merger with Nippon Steel Corporation (&#34;NSC&#34;), marking a key milestone toward the completion of the transaction.


U.S. Steel Shareholders Clear Transaction with Nippon Steel

Penny Stocks

Small Cap

Coeur Mining, Inc. (NYSE: CDE) announced that its newly expanded Rochester silver and gold mine in Nevada achieved commercial production.


Coeur&#39;s (CDE) Rochester Mine Starts Commercial Operation

Earnings

Dividends

Buybacks

After-Hours Center

Innospec Inc. (NASDAQ: IOSP) shares are trading lower by 2.37% to $109.97 during Tuesday&#39;s after-hours session. The company reported mixed fourth-quarter financial results.

What Happened?

Why Innospec Stock Is Falling During Tuesday&#39;s After-Hours Session

Innospec Inc

United States Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) said that its shareholders have approved its proposed merger with Nippon Steel Corporation (&quot;NSC&quot;), marking a key milestone toward the completion of the transaction. 
More than 98% of the shares voted at the special meeting of stockholders held on Apr 12, 2024 were voted in favor of the proposal to adopt the merger agreement, based on the preliminary vote count. 
U.S. Steel stated that the overwhelming support from its shareholders is a clear recognition of the compelling rationale for the deal. The transaction will strengthen U.S. Steel and the domestic steel industry and enhance the legacy of steel that is made in America in the wake of unfair competition from China, X noted. 
U.S. Steel and NSC officially entered into a definitive agreement in December 2023, under which, NSC agreed to acquire U.S. Steel in an all-cash deal at $55 per share. The transaction is valued at roughly $14.1 billion-plus assumed debt, equating to a total enterprise value of $14.9 billion. The purchase price of $55 per share represents a substantial 40% premium over U.S. Steel&#39;s closing stock price as of Dec 15, 2023. 
NSC noted that the strategic move to acquire U.S. Steel is aimed at augmenting its global manufacturing and technology capabilities. The acquisition will facilitate an expansion of NSC&#39;s geographical reach, allowing it to better serve stakeholders, including customers and society at large. This strategic expansion will notably increase NSC&#39;s production in the United States, complementing its existing strongholds in Japan, ASEAN and India. 
With the acquisition, NSC&#39;s total annual crude steel capacity is expected to reach 86 million tons, aligning with its strategic objective of achieving 100 million tons of global crude steel capacity annually. NSC also underscored the synergies arising from the transaction, emphasizing the amalgamation of cutting-edge technologies and manufacturing capabilities. 
However, the deal has drawn significant opposition from the Biden administration on concerns about the implications on U.S. national security, supply chains and steel jobs. President Joe Biden, last month, said that U.S. Steel should remain American owned and operated. The U.S. Department of Justice has reportedly launched an extended antitrust investigation into the proposed merger. The United Steelworkers union has also expressed concerns of potential job losses from the transaction. 
U.S. Steel&#39;s shares have rallied 57.4% over the past year, outperforming the 11.3% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/3d/64986.jpg?v=830857229" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
U.S. Steel currently carries a Zacks Rank #3 (Hold). 
Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. (AMEX:DNN), Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>). 
Denison Mines beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 300%. The company&#39;s shares have soared roughly 105% in the past year. DNN carries a Zacks Rank #1 (Strong Buy). 
The Zacks Consensus Estimate for Carpenter Technology&#39;s current fiscal year earnings is pegged at $3.96, indicating a year-over-year surge of 247.4%. CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 12.2%. The company&#39;s shares have rallied around 68% in the past year. CRS currently carries a Zacks Rank #2 (Buy). 
The consensus estimate for Innospec&#39;s current-year earnings is pegged at $6.72 per share, indicating a 10.3% year-over-year rise. IOSP, carrying a Zacks Rank #2, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 10.5%. The company&#39;s shares have gained around 14% in the past year.
<a href="https://www.zacks.com/stock/news/2255178/u-s-steel-x-shareholders-clear-transaction-with-nippon-steel?cid=CS-BENZ-FT-analyst_blog|company_news_-_corporate_actions-2255178">To read this article on Zacks.com click here.</a>

Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) announced that its newly expanded Rochester silver and gold mine in Nevada achieved commercial production. 
On Mar 7, the new three-stage crushing circuit and truck load-out facility were officially commissioned. Since then, the crusher circuit has operated at an average throughput of more than 70,000 tons per day and has topped 88,000 tons per day. This led to the declaration of commercial production by the end of the first quarter. 
Backed by this, the company additionally stated that the ramp-up to full planned capacity of 88,000 tons per day (about 32 million tons per year) is scheduled to be completed in the first half of 2024. With commissioning completed and ramp-up progressing well, the company will be able to shift its focus to mine optimization activities and business development programs aimed at maximizing the value of this world-class, long-life asset. 
Once fully operational, throughput levels are estimated to be 2.5 times higher than in the past, making Rochester one of the world&#39;s largest open-pit heap leach operations. It is expected to be America&#39;s largest source of domestically produced and processed silver, as well as a key driver of CDE&#39;s cash flow growth. 
In the fourth quarter of 2023, the company reported an adjusted loss of 2 cents per share, whereas the Zacks Consensus Estimate was pegged at breakeven. The company recorded revenues of $262 million in the quarter.
<h3>Price Performance</h3>
Coeur&#39;s shares have gained 15.3% in the past year compared with the industry&#39;s 34.7% growth.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/70/64608.jpg?v=842630886" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Stocks to Consider</h3>
Coeur currently carries a Zacks Rank #3 (Hold). 
Some better-ranked stocks from the basic materials space are Ecolab Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ecl#NYSE">ECL</a>), Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>). ECL and CRS sport a Zacks Rank #1 (Strong Buy) at present, and IOSP has a Zacks Rank #2 (Buy). 
The Zacks Consensus Estimate for Ecolab&#39;s 2024 earnings is pegged at $6.39 per share, indicating an increase of 22.7% from the prior year&#39;s reported number. It has an average trailing four-quarter earnings surprise of 1.7%. ECL shares have gained 41.8% in a year. 
The Zacks Consensus Estimate for Carpenter Technology&#39;s 2024 earnings is pegged at $4 per share. The consensus estimate for 2024 earnings has moved 1% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 14.3%. CRS shares have gained 33.5% in a year. 
The Zacks Consensus Estimate for Innospec&#39;s 2024 earnings is pegged at $6.72 per share, indicating a year-over-year rise of 10.3%. The Zacks Consensus Estimate for IOSP&#39;s current-year earnings has been revised 2% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 10.5%. The company&#39;s shares have rallied 19.3% in the past year.
<a href="https://www.zacks.com/stock/news/2252780/coeur-s-cde-rochester-mine-starts-commercial-operation?cid=CS-BENZ-FT-analyst_blog|company_news_-_corporate_actions-2252780">To read this article on Zacks.com click here.</a>

Coeur's (CDE) Rochester Mine Starts Commercial Operation

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.84 per share which beat the analyst consensus estimate of $1.62 by 13.58 percent. This is a 53.33 percent increase over earnings of $1.20 per share from the same period last year. The company reported quarterly sales of $494.70 million which beat the analyst consensus estimate of $479.47 million by 3.18 percent. This is a 3.13 percent decrease over sales of $510.70 million the same period last year.

Innospec Q4 EPS $1.84 Beats $1.62 Estimate, Sales $494.70M Beat $479.47M Estimate

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported its Q4 earnings results on Tuesday, February 13, 2024 at 04:45 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Innospec beat estimated earnings by 13.58%, reporting an EPS of $1.84 versus an estimate of $1.62.
Revenue was down $16.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.14 which was followed by a 1.97% increase in the share price the next day.
Here's a look at Innospec's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.45</td>
<td>1.31</td>
<td>1.17</td>
<td>1.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.59</td>
<td>1.28</td>
<td>1.38</td>
<td>1.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>481.17M</td>
<td>498.47M</td>
<td>496.47M</td>
<td>485.73M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>464.10M</td>
<td>480.40M</td>
<td>509.60M</td>
<td>510.70M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Innospec <a href="https://www.benzinga.com/quote/IOSP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Innospec: Q4 Earnings Insights

ABNB

AKAM

AKTS

ALSN

ANGI

ATOM

BENF

BFAM

BIIB

BRKR

CART

CHCT

CRSR

CTHR

DDOG

DENN

DNUT

ELMD

ENTG

FELE

GCMG

GDDY

GNSS

GORO

HOOD

HYLN

INCY

INMD

INVH

IPGP

KTOS

LCII

LDOS

LOPE

LYFT

MODG

NMTC

NTWK

QDEL

REZI

ROIV

RUSHA

RUSHB

SHOP

SITC

SITM

SMWB

SSNC

STAG

TYGO

UFCS

UPST

USAC

VTGN

Earnings Scheduled For February 13, 2024

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here's what investors need to know before the announcement.
Analysts estimate that Innospec will report an earnings per share (EPS) of $1.62. 
Innospec bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.14, which was followed by a 1.97% increase in the share price the next day.
Here's a look at Innospec's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.45</td>
<td>1.31</td>
<td>1.17</td>
<td>1.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.59</td>
<td>1.28</td>
<td>1.38</td>
<td>1.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.97%</td>
<td>3.09%</td>
<td>1.41%</td>
<td>-3.41%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707750067_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Innospec were trading at $118.9 as of February 09. Over the last 52-week period, shares are up 5.0%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/IOSP/earnings">To track all earnings releases for Innospec visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Innospec

Founded in 1992, QGP has 300 employees. Innospec will integrate QGP into its Performance Chemicals business.

Innospec Completes Acquisition Of QGP Química Geral, A Specialty Chemicals Company Based In Brazil; Terms Not Disclosed

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.45 by 9.66 percent. This is a 8.62 percent decrease over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $464.10 million which missed the analyst consensus estimate of $481.17 million by 3.55 percent. This is a 9.53 percent decrease over sales of $513.00 million the same period last year.

Earnings Beats

Earnings Misses

Innospec Q3 Adj $1.59 Beats $1.45 Estimate, Sales $464.10M Miss $481.17M Estimate

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly Adj earnings of $1.28 per share which missed the analyst consensus estimate of $1.31 by 2.29 percent. This is a 18.99 percent decrease over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $480.40 million which missed the analyst consensus estimate of $498.47 million by 3.63 percent. This is a 2.74 percent increase over sales of $467.60 million the same period last year.

Innospec Q2 Adj EPS $1.28 Misses $1.31 Estimate, Sales $480.40M Miss $498.47M Estimate

WIIM

AVNT

BCPC

CTVA

LTHM

MEOH

NGVT

TANH

TROX

Shares of chemical companies are trading higher amid overall market strength on renewed economic optimism following US Senate passage of a debt limit bill and strong US jobs data.

<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data,</a> Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) posted Q1 earnings of $33.20 million, an increase from Q4 of 30.2%. Sales dropped to $509.60 million, a 0.22% decrease between quarters. In Q4, Innospec earned $25.50 million, whereas sales reached $510.70 million. 
<h3>What Is ROCE?</h3>
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q1, Innospec posted an ROCE of 0.03%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Innospec is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth. 
For Innospec, the positive return on capital employed ratio of 0.03% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
Innospec reported Q1 earnings per share at $1.38/share, which beat analyst predictions of $1.17/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Innospec's Return On Capital Employed Insights

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Innospec beat estimated earnings by 17.95%, reporting an EPS of $1.38 versus an estimate of $1.17.
Revenue was up $37.20 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.19 which was followed by a 3.41% drop in the share price the next day.
Here's a look at Innospec's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.39</td>
<td>1.41</td>
<td>1.35</td>
<td>1.19</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.20</td>
<td>1.74</td>
<td>1.58</td>
<td>1.53</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>485.73M</td>
<td>464.00M</td>
<td>439.43M</td>
<td>397.67M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>510.70M</td>
<td>513.00M</td>
<td>467.60M</td>
<td>472.40M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Innospec <a href="https://www.benzinga.com/quote/IOSP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Innospec Q1 Earnings

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly adjusted earnings of $1.38 per share which beat the analyst consensus estimate of $1.17 by 17.95 percent. This is a 9.8 percent decrease over earnings of $1.53 per share from the same period last year. The company reported quarterly sales of $509.60 million which beat the analyst consensus estimate of $496.47 million by 2.64 percent. This is a 7.87 percent increase over sales of $472.40 million the same period last year.

Innospec Q1 Adj EPS $1.38 Beats $1.17 Estimate, Sales $509.60M Beat $496.47M Estimate

Ian Cleminson, VP &amp; CFO at Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>), reported a large exercise of company stock options on March 9, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001054905/000120919123017646//Archives/edgar/data/1054905/000120919123017646/0001209191-23-017646-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Cleminson, VP &amp; CFO at Innospec, a company in the Materials sector, just exercised stock options worth 6,079 shares of IOSP stock with an exercise price of $13.48.
Innospec shares are trading down 1.67% at $102.42 at the time of this writing on Friday morning. Since the current price is $102.42, this makes Cleminson's 6,079 shares worth $622,580.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001054905">Check Out The Full List Of Innospec's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

VP & CFO at Innospec Exercises Options Worth $622K

Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>)&nbsp;shares are trading lower by 2.37% to&nbsp;$109.97&nbsp;during Tuesday&#39;s after-hours session. The company&nbsp;reported mixed&nbsp;fourth-quarter&nbsp;financial results.
What Happened?
Innospec&nbsp;reported quarterly earnings of&nbsp;$1.20&nbsp;per share, which missed the analyst consensus estimate of&nbsp;$1.39. The company also reported quarterly sales of&nbsp;$510.70 million&nbsp;that beat the analyst consensus estimate of&nbsp;$485.73 million&nbsp;by&nbsp;5%. This sales figure is a&nbsp;23.6%&nbsp;increase over sales of&nbsp;$413.2&nbsp;million in the same period last year.
See Also:&nbsp;<a href="https://www.benzinga.com/news/earnings/23/02/30993475/why-donnelley-financial-solutions-dfin-shares-are-getting-hammered" title="Why Donnelley Financial Solutions (DFIN) Shares Are Getting Hammered">Why Donnelley Financial Solutions (DFIN) Shares Are Getting Hammered</a>
Innospec says the company generated cash from operating activities of&nbsp;$78.4 million&nbsp;before capital expenditures of&nbsp;$15.1 million&nbsp;in the quarter. Innospec also closed the quarter with net cash of&nbsp;$147.1 million, up from net cash of $100.5 million&nbsp;at the end of the&nbsp;third quarter.
In the&nbsp;fourth quarter, the company says it paid its semi-annual dividend of 65 cents per common share and repurchased 8,514 of its common shares at a cost of&nbsp;$700,000.
What Else?
Commenting on the&nbsp;fourth quarter&nbsp;results, Patrick S. Williams, president and CEO, said:&nbsp;&quot;This was another very strong quarter for Innospec. In the quarter and the full-year we delivered double-digit sales and operating income growth with expanded margins. We again benefited from our balanced end-market exposure as some negative impact of year-end customer destocking in Performance Chemicals was offset by continued sequential growth in Oilfield Services and steady results in Fuel Specialties.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, IOSP&nbsp;has a 52-week high of&nbsp;$115.66 and a 52-week low of&nbsp;$83.13.
Photo via Shutterstock.&nbsp;

Why Innospec Stock Is Falling During Tuesday's After-Hours Session

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.20 per share which missed the analyst consensus estimate of $1.39 by 13.67 percent. This is a 7.69 percent decrease over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $510.70 million which beat the analyst consensus estimate of $485.73 million by 5.14 percent. This is a 23.60 percent increase over sales of $413.20 million the same period last year.

Innospec Q4 EPS $1.20 Misses $1.39 Estimate, Sales $510.70M Beat $485.73M Estimate

ETRN

EXAS

EXPD

FANG

GMED

HALO

HCKT

HRMY

ICCC

JBGS

JELD

KEYS

LAND

LECO

LGIH

MATX

MFIC

MICS

MIDD

MTDR

NXRT

PANW

PTCT

PUMP

QTWO

QUAD

SAND

SBAC

SBRA

SOHU

SPNS

STAA

STAR

TALK

TCMD

TECK

TFPM

TRTX

Hostess Brands, Inc. - Class A Common Stock

TWNK

UFPI

UNVR

VNOM

VNTR

WLKP

WTTR

XPER

Earnings Scheduled For February 21, 2023

<h1>&nbsp;</h1>
During Monday&#39;s session, 50 stocks hit new 52-week highs.
<h2>Noteworthy Highlights From Today&#39;s 52-Week Lows:</h2>
<ul>
<li>The largest company on a market cap basis to set a new 52-week high was Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>).</li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) was the smallest firm in terms of market cap to set a new 52-week high.</li>
<li>Imago BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMGO#NASDAQ">IMGO</a>) was the biggest gainer, trading up 104.05% to reach its 52-week high.</li>
<li>Bank of Princeton (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPRN#NASDAQ">BPRN</a>) was the biggest loser of the group, declining 0.03% after reaching its new 52-week high.</li>
</ul>
On Monday, the following stocks hit new 52-week highs:
<ul>
<li>Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) shares set a new yearly high of $105.17 this morning. The stock was up 0.59% on the session.</li>
<li>PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) shares reached a new 52-week high of $184.23 on Monday morning, moving up 1.35%.</li>
<li>Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) shares were up 1.18% for the day, having made a 52-week high of $84.78.</li>
<li>O&#39;Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) shares were up 1.04% on Monday morning to hit a new 52-week high of $849.26.</li>
<li>Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) shares hit $100.88 on Monday morning, setting a new 52-week high for a change of up 0.77%.</li>
<li>Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) shares broke to a new 52-week high of $454.37 on Monday. Shares of the company traded up 0.86%.</li>
<li>Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) shares were up 0.67% on Monday to hit a new 52-week high of $196.58 for a change of up 0.67%.</li>
<li>Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) shares achieved a new 52-week high on Monday morning, hitting $43.94 with a daily change of up 0.49%.</li>
<li>Cia Paranaense De Energia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELP#NYSE">ELP</a>) shares broke to a new 52-week high of $8.25 on Monday. Shares of the company traded up 21.99%.</li>
<li>Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) shares broke to $68.11 on Monday, setting a new 52-week high with a change of up 1.65%.</li>
<li>First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) shares achieved a new 52-week high on Monday morning, hitting $167.59 with a daily change of down 0.31%.</li>
<li>RPM International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) shares broke to a new 52-week high of $102.05 on Monday. Shares of the company traded up 1.3%.</li>
<li>Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) shares set a new 52-week high of $237.87 on Monday, moving up 0.51%.</li>
<li>Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares hit $377.43 on Monday morning, setting a new 52-week high for a change of down 1.88%.</li>
<li>Commerce Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBSH#NASDAQ">CBSH</a>) stock on Monday broke to a yearly high of $73.66. Shares traded up 0.71%.</li>
<li>EMCOR Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) shares broke to a new 52-week high of $155.97 on Monday. Shares of the company traded up 0.08%.</li>
<li>New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) shares were up 0.6% on Monday morning to hit a new 52-week high of $48.48.</li>
<li>Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) shares hit a new 52-week high of $91.11. The stock traded up 1.04% on the session.</li>
<li>Euronav (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EURN#NYSE">EURN</a>) shares broke to a new 52-week high of $20.75 on Monday. Shares of the company traded down 0.35%.</li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) stock set a new 52-week high of $32.43 Monday morning. Over the session, the stock traded up 3.18%.</li>
<li>Immunocore Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) shares were up 5.23% for the day, having made a 52-week high of $69.06.</li>
<li>Frontline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) shares achieved a new 52-week high on Monday morning, hitting $14.74 with a daily change of down 0.17%.</li>
<li>e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) stock hit a yearly high price of $55.65. The stock was up 0.36% for the day.</li>
<li>Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) stock set a new 52-week high of $114.48 Monday morning. Over the session, the stock traded up 0.57%.</li>
<li>SJW Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NYSE">SJW</a>) stock on Monday broke to a yearly high of $74.69. Shares traded up 1.33%.</li>
<li>Griffon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFF#NYSE">GFF</a>) shares hit a new 52-week high of $36.34. The stock traded down 2.38% on the session.</li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock made a new 52-week high of $8.32 Monday. The stock was up 36.42% for the day.</li>
<li>KKR Acquisition Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAHC#NYSE">KAHC</a>) shares broke to $10.04 on Monday, setting a new 52-week high with a change of up 0.3%.</li>
<li>Digi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGII#NASDAQ">DGII</a>) shares achieved a new 52-week high on Monday morning, hitting $43.04 with a daily change of up 3.13%.</li>
<li>GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) shares set a new yearly high of $10.29 this morning. The stock was up 4.29% on the session.</li>
<li>Imago BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMGO#NASDAQ">IMGO</a>) shares achieved a new 52-week high on Monday morning, hitting $35.75 with a daily change of up 104.05%.</li>
<li>Bank First (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFC#NASDAQ">BFC</a>) shares achieved a new 52-week high on Monday morning, hitting $95.77 with a daily change of up 1.67%.</li>
<li>Greene County Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCBC#NASDAQ">GCBC</a>) stock set a new 52-week high of $73.98 Monday morning. Over the session, the stock traded down 0.6%.</li>
<li>Ardmore Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASC#NYSE">ASC</a>) shares broke to $14.88 on Monday, setting a new 52-week high with a change of down 1.7%.</li>
<li>Covenant Logistics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLG#NASDAQ">CVLG</a>) shares were up 0.73% on Monday to hit a new 52-week high of $40.35 for a change of up 0.73%.</li>
<li>IBEX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBEX#NASDAQ">IBEX</a>) stock on Monday broke to a yearly high of $26.93. Shares traded up 3.7%.</li>
<li>Preformed Line Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLPC#NASDAQ">PLPC</a>) shares hit $89.32 on Monday morning, setting a new 52-week high for a change of up 0.93%.</li>
<li>FinTech Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCV#NASDAQ">FTCV</a>) stock set a new 52-week high of $10.05 Monday morning. Over the session, the stock traded up 0.15%.</li>
<li>Northrim BanCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIM#NASDAQ">NRIM</a>) shares broke to a new 52-week high of $54.95 on Monday. Shares of the company traded down 0.76%.</li>
<li>PCSB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSB#NASDAQ">PCSB</a>) shares achieved a new 52-week high on Monday morning, hitting $19.97 with a daily change of up 0.15%.</li>
<li>Willis Lease Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLFC#NASDAQ">WLFC</a>) stock on Monday broke to a yearly high of $46.74. Shares traded up 2.78%.</li>
<li>Norwood Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWFL#NASDAQ">NWFL</a>) stock set a new 52-week high of $30.69 Monday morning. Over the session, the stock traded up 0.43%.</li>
<li>Western New England (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNEB#NASDAQ">WNEB</a>) shares achieved a new 52-week high on Monday morning, hitting $9.75 with a daily change of up 2.96%.</li>
<li>Bank of Princeton (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPRN#NASDAQ">BPRN</a>) shares achieved a new 52-week high on Monday morning, hitting $32.21 with a daily change of up 0.03%.</li>
<li>Puma Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBYI#NASDAQ">PBYI</a>) stock made a new 52-week high of $4.43 Monday. The stock was up 16.0% for the day.</li>
<li>BioVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) stock on Monday broke to a yearly high of $5.94. Shares traded up 1.41%.</li>
<li>China Automotive Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAAS#NASDAQ">CAAS</a>) shares hit a yearly high of $5.37. The stock traded up 9.18% on the session.</li>
<li>Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) shares broke to $34.51 on Monday, setting a new 52-week high with a change of down 0.86%.</li>
<li>Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) shares broke to a new 52-week high of $2.43 on Monday. Shares of the company traded up 7.05%.</li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares broke to a new 52-week high of $3.23 on Monday. Shares of the company traded up 50.56%.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

Options

BIVI

BPRN

CAAS

CBSH

CLMB

CTAS

CVLG

DECK

DGII

EURN

FSLR

FTCV

GCBC

GILD

GMAB

HGBL

IBEX

IMCR

IMGO

KAHC

MNST

NRIM

NWFL

NWTN

ORLY

PBYI

PCSB Financial Corporation - Common Stock

PCSB

PLPC

SHLS

WLFC

WNEB

Stocks That Hit 52-Week Lows On Monday

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $1.41 by 23.4 percent. This is a 51.3 percent increase over earnings of $1.15 per share from the same period last year. The company reported quarterly sales of $513.00 million which beat the analyst consensus estimate of $464.00 million by 10.56 percent. This is a 36.40 percent increase over sales of $376.10 million the same period last year.

Innospec Q3 EPS $1.74 Beats $1.41 Estimate, Sales $513.00M Beat $464.00M Estimate